Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Find a clinical trial that's recruiting now
Search 24,857 actively recruiting US clinical trials by condition, drug, or state, each entry links straight to its NIH ClinicalTrials.gov record so you can check eligibility and contact the study team.
- 24,857
- trials recruiting now
- 14%
- of all US trials open to enrollment
- 52
- states with recruiting sites
A trial is listed as recruiting when its sponsor has marked it open to new participants on the public registry. Type a condition or drug name (for example, "breast cancer" or "pembrolizumab") to narrow the list, and add a state to find studies with a site near you. Results are ordered with the most relevant recruiting studies first; each card shows the study phase and enrollment target, and opens the full record, including eligibility criteria and contact details, on ClinicalTrials.gov.
Popular conditions
Showing the 40 largest recruiting trials by target enrollment in Vermont. Use the search field to focus on a condition or drug.
Vermont Oxford Network Very Low Birth Weight Database
Vermont Oxford Network
NCT01825499
Endoscopic Resection of Large Colorectal Polyps: An Observational Cohort Study
White River Junction Veterans Affairs Medical Center
NCT04220905
Deep Functional Phenotyping of the ALA Lung Health Cohort
Johns Hopkins University
NCT06177717
International CIPN Assessment and Validation Study
University of Milano Bicocca
NCT04633655
PanTheR Registry Trial
RenovoRx
NCT06805461
DOAC - Dosing Options in AntiCoagulation Prophylaxis
University of Vermont
NCT07005024
Prehospital Analgesia INtervention Trial (PAIN)
Jason Sperry
NCT05437575
A Study Comparing Oral Buprenorphine and Injectable Buprenorphine for the Treatment of Opioid Use Disorder
VA Office of Research and Development
NCT04375033
ELEVATE-HFpEF Clinical Study
Medtronic Cardiac Rhythm and Heart Failure
NCT06678841
Longitudinal Bladder Cancer Study for Tumour Recurrence
Pacific Edge Limited
NCT05080998
Remote Monitoring and Management of Chemotherapy Induced Peripheral Neuropathy
University of Vermont
NCT04763356
Nicotine Regulation for Dual Users of E-cigarettes and Cigarettes
University of Vermont
NCT06614504
Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood And Bone Marrow Specimens From Children And Young Adults With Hematologic Malignancy
Dana-Farber Cancer Institute
NCT04968834
Safety and Efficacy of EXV-802 and EXV-801 in the Treatment of Agitation in Alzheimer's Disease Dementia
Exciva
NCT07284472
Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
NCT06463587
Study to Evaluate Efficacy & Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer
Laekna Limited
NCT04851613
Evaluation of VX-828 in Healthy Participants and in Participants With Cystic Fibrosis
Vertex Pharmaceuticals Incorporated
NCT06154447
Endocardial Mapping With the CoreMap EP Mapping System
CoreMap
NCT06529978
Replacing Invasive Cystoscopy With Urine Testing for Non-muscle Invasive Bladder Cancer Surveillance
White River Junction Veterans Affairs Medical Center
NCT05796375
PRESERVE & CONNECT: Impact Study of the BPC
University of Vermont
NCT06160050
Nutritional Prehabilitation to Improve Cancer Outcomes (N-PICO)
University of Vermont Medical Center
NCT07072377
Evaluation of VX-121/Tezacaftor/Deutivacaftor in Cystic Fibrosis (CF) Participants 1 Through 11 Years of Age
Vertex Pharmaceuticals Incorporated
NCT05422222
LEMURS SSI: Evaluation of Behavioral Incentives
University of Vermont
NCT06340841
Expanding the Support of Family Caregivers of Diverse Patients With Cancer and Diabetes
UNC Lineberger Comprehensive Cancer Center
NCT07061652
Novel Telemedicine-Delivered Prolonged Exposure Therapy for Treating PTSD in Individuals With OUD
University of Vermont
NCT06288711
A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)
Johnson & Johnson Enterprise Innovation
NCT06667908
Suicide Prevention After Community Care Discharge
VA Office of Research and Development
NCT06596044
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
Janssen Research & Development
NCT05923073
His-Bundle Corrective Pacing in Heart Failure
University of Rochester
NCT05265520
Optimizing Aerobic Fitness in Older Adults
University of Vermont Medical Center
NCT06951620
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
Cardiol Therapeutics
NCT06708299
Fast Induced Remodeling in Heart Failure With Preserved Ejection Fraction
Medtronic Cardiac Rhythm and Heart Failure
NCT05839730
Hybrid Arc Palliative Radiation Therapy (HART): A Single Arm Phase II Trial
University of Vermont Medical Center
NCT06778408
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
Prakash Pandalai
NCT04779554
Glecaprevir/Pibrentasvir for Post-traumatic Stress Disorder
White River Junction Veterans Affairs Medical Center
NCT05637879
A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
Eli Lilly and Company
NCT05509777
Sinus Disease in Young Children With Cystic Fibrosis
University of California, Los Angeles
NCT06191640
Comparing the Effectiveness of the 'Think in Nerve Length and Layers' (TINLL) Approach to Traditional Treatment for Patients With Lateral Elbow Pain.
University of Vermont
NCT07385677
Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer
BicycleTx Limited
NCT06840483
Fatty Acid Modulation of Brain Function in Older Adults
University of Vermont
NCT06192407
Read our methodology - how recruiting status is sourced and refreshed from the public registry.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Recruiting status is reported by each study's sponsor and mirrored from the public registry. Always confirm current eligibility and status on ClinicalTrials.gov before contacting a study.